Mackenzie Financial Corp Ionis Pharmaceuticals Inc Transaction History

Mackenzie Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $250,542 - $343,383	-9,783 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $415,875 - $623,959	9,783 New	9,783 $440,000
Q4 2018 Feb 06, 2019	SELL	$43.37 - $59.54 $221,620 - $304,249	-5,110 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$42.88 - $53.7 $111,959 - $140,210	-2,611 Reduced 33.82%	5,110 $264,000
Q2 2018 Aug 13, 2018	SELL	$40.53 - $50.7 $61,321 - $76,709	-1,513 Reduced 16.39%	7,721 $322,000
Q1 2018 May 14, 2018	BUY	$44.08 - $55.05 $153,706 - $191,959	3,487 Added 60.68%	9,234 $407,000
Q4 2017 Feb 13, 2018	BUY	$50.3 - $64.39 $289,074 - $370,049	5,747	5,747 $289,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.